Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
187 | 3 | NEUROTROPHINS//BDNF//BRAIN DERIVED NEUROTROPHIC FACTOR | 55761 |
873 | 2 | NEUROTROPHINS//BRAIN DERIVED NEUROTROPHIC FACTOR//BDNF | 11647 |
18967 | 1 | TRKB//TRKA//TRKA INHIBITOR | 551 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | TRKB | authKW | 269057 | 11% | 8% | 60 |
2 | TRKA | authKW | 256395 | 9% | 9% | 52 |
3 | TRKA INHIBITOR | authKW | 228793 | 1% | 100% | 4 |
4 | LOXO 101 | authKW | 183032 | 1% | 80% | 4 |
5 | AZ64 | authKW | 171594 | 1% | 100% | 3 |
6 | NTRK1 2 3 | authKW | 171594 | 1% | 100% | 3 |
7 | MOL DIS CELL REGULAT | address | 171588 | 1% | 50% | 6 |
8 | P75NTR | authKW | 135208 | 6% | 7% | 32 |
9 | TROPOMYOSIN RECEPTOR KINASE | authKW | 129990 | 1% | 45% | 5 |
10 | TROPOMYOSIN RECEPTOR KINASES | authKW | 128694 | 1% | 75% | 3 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 4942 | 49% | 0% | 271 |
2 | Cell Biology | 472 | 17% | 0% | 91 |
3 | Biochemistry & Molecular Biology | 228 | 21% | 0% | 113 |
4 | Chemistry, Medicinal | 214 | 7% | 0% | 36 |
5 | Pathology | 205 | 6% | 0% | 33 |
6 | Endocrinology & Metabolism | 35 | 4% | 0% | 24 |
7 | Medicine, Research & Experimental | 34 | 4% | 0% | 23 |
8 | Pharmacology & Pharmacy | 28 | 7% | 0% | 38 |
9 | Genetics & Heredity | 26 | 4% | 0% | 24 |
10 | Urology & Nephrology | 20 | 3% | 0% | 14 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOL DIS CELL REGULAT | 171588 | 1% | 50% | 6 |
2 | U GROWTH TOR SIGNALING BREAST CANC CELLS FUNCT | 114396 | 0% | 100% | 2 |
3 | VINCENT T LOMBARDI COMPREHENS CANC | 102133 | 1% | 36% | 5 |
4 | U908 | 65168 | 1% | 16% | 7 |
5 | ABRAHAMSON 916 | 57198 | 0% | 100% | 1 |
6 | AFFILIATED PLA CLIN | 57198 | 0% | 100% | 1 |
7 | AFLAC CANC BLOOD SERV | 57198 | 0% | 100% | 1 |
8 | BIOL CHEM PHARMACEUT SCI | 57198 | 0% | 100% | 1 |
9 | CANCEROL LYONCNRSU1052UMR5286EQUIPE EL | 57198 | 0% | 100% | 1 |
10 | CELLULAR HOMEOSTASIS DIS | 57198 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | GROWTH FACTORS | 1126 | 1% | 0% | 4 |
2 | ONCOLOGY REPORTS | 1057 | 3% | 0% | 14 |
3 | CLINICAL CANCER RESEARCH | 1056 | 3% | 0% | 17 |
4 | CANCER DISCOVERY | 984 | 1% | 1% | 3 |
5 | EXPERT OPINION ON THERAPEUTIC PATENTS | 892 | 1% | 0% | 6 |
6 | PROSTATE | 776 | 1% | 0% | 8 |
7 | CLINICAL & EXPERIMENTAL METASTASIS | 697 | 1% | 0% | 5 |
8 | CANCER RESEARCH | 610 | 4% | 0% | 21 |
9 | ONCOGENE | 586 | 3% | 0% | 14 |
10 | INVESTIGATIONAL NEW DRUGS | 542 | 1% | 0% | 5 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRKB | 269057 | 11% | 8% | 60 | Search TRKB | Search TRKB |
2 | TRKA | 256395 | 9% | 9% | 52 | Search TRKA | Search TRKA |
3 | TRKA INHIBITOR | 228793 | 1% | 100% | 4 | Search TRKA+INHIBITOR | Search TRKA+INHIBITOR |
4 | LOXO 101 | 183032 | 1% | 80% | 4 | Search LOXO+101 | Search LOXO+101 |
5 | AZ64 | 171594 | 1% | 100% | 3 | Search AZ64 | Search AZ64 |
6 | NTRK1 2 3 | 171594 | 1% | 100% | 3 | Search NTRK1+2+3 | Search NTRK1+2+3 |
7 | P75NTR | 135208 | 6% | 7% | 32 | Search P75NTR | Search P75NTR |
8 | TROPOMYOSIN RECEPTOR KINASE | 129990 | 1% | 45% | 5 | Search TROPOMYOSIN+RECEPTOR+KINASE | Search TROPOMYOSIN+RECEPTOR+KINASE |
9 | TROPOMYOSIN RECEPTOR KINASES | 128694 | 1% | 75% | 3 | Search TROPOMYOSIN+RECEPTOR+KINASES | Search TROPOMYOSIN+RECEPTOR+KINASES |
10 | CEP 2563 | 114396 | 0% | 100% | 2 | Search CEP+2563 | Search CEP+2563 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |